NeuroTherapeutics
2502 North Clark Street #216
Chicago, IL 60614
Phone: (312) 883-8585
Fax: (312) 935-2132
E-Mail: JLeestma@aol.com
NeuroTherapeutics is a startup drug development company using antibody
engineering technologies to develop peptides, peptoids and mimetics acting
on CNS membrane receptors.
Current focus is a memory/cognition enhancing drug which is a small
peptide acting as partial agonist at glycine site of NMDA receptor, functionally
active in-vitro and in-vivo. Seek strategic alliances and other relationships
with other Biotech companies with interests in NMDA receptor-acting drugs
to engage in final development and development of other drugs.
Paul Marangos, Ph.D.
(619) 455-6093
President & Founder
NeuroTherapeutics Corporation
San Diego, California
Martin Nash
(619) 455-6174
Chief Executive Officer
NeuroTherapeutics Corporation
San Diego, California
Return to table of contents.
E-mail me.